Company

Akroswiss

Pharmaceutical Manufacturing Zug, Ch 5 employees

Employees: 5
Contacts: 2
Emails: 2

www.akroswiss.ch LinkedIn Crunchbase

Akroswiss Overview

Headquarters: Zug, Ch
Website: www.akroswiss.ch
Industry: Pharmaceutical Manufacturing
Employees: 5
Funding: 3.3M
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Klus-Apotheke

About Akroswiss

Akroswiss is a swiss based pharmaceutical company, fully dedicated to the development and commercialization of innovative nasal applications of midazolam. Akroswiss has successfully developed and tested a unique bi-dose nasal drug delivery device with a first-class 360° functionality which address two unmet clinical needs; efficient treatment of epileptic seizures (rescue medication use) and conscious sedation ahead of diagnostic interventions against claustrophobia and restlessness (anxiolytic use). Akroswiss is pursuing European market authorization of its midazolam product portfolio and is currently compiling all documentation required for EMA submission.

Akroswiss Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Akroswiss Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jonas Steinhauser	Resourceful and Versatile R&D Leader with a Unique Combination of Skills Develops Innovative Products for Akroswiss.	Zurich, Switzerland	View
Olha Würthinger	Pharmaceutical Consultant / Swiss Federal Pharmacist Eth	Zurich, Switzerland	View
Marc Fröhlich	CEO at Akroswiss - Program Lead at Swiss Cardio Technologie - Board Member at Klus-apotheke	Zurich, Switzerland	Email
Schuknecht Bernhard	Prof. Dr. Med. Medizinisch Radiologisches Institut Zürich	Zurich, Switzerland	Email